Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.66 USD | +1.22% | +9.21% | -12.17% |
Mar. 25 | HC Wainwright Cuts Price Target on Rockwell Medical to $9 From $11, Keeps Buy Rating | MT |
Mar. 21 | Transcript : Rockwell Medical, Inc., Q4 2023 Earnings Call, Mar 21, 2024 |
Business Summary
Number of employees: 237
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Concentrate Products
97.2
%
| 72 | 98.4 % | 81 | 97.2 % | +13.43% |
Drug
2.8
%
| 1 | 1.6 % | 2 | 2.8 % | +101.73% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
88.9
%
| 66 | 90.3 % | 74 | 88.9 % | +13.04% |
Rest of World
11.1
%
| 7 | 9.7 % | 9 | 11.1 % | +31.57% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mark Strobeck
CEO | Chief Executive Officer | 53 | 22-06-30 |
Jesse Neri
DFI | Director of Finance/CFO | - | 23-10-17 |
Marc Hoffman
CTO | Chief Tech/Sci/R&D Officer | 63 | 19-11-19 |
Timothy T. Chole
SAM | Sales & Marketing | - | 19-11-30 |
Michael DeYoung
PRN | Corporate Officer/Principal | - | 18-12-09 |
Megan Timmins
LAW | General Counsel | 52 | 21-07-31 |
Corporate Officer/Principal | - | 22-09-06 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Cooper
BRD | Director/Board Member | 65 | 17-09-06 |
Allen Nissenson
BRD | Director/Board Member | 77 | 20-06-10 |
Mark Strobeck
CEO | Chief Executive Officer | 53 | 22-06-30 |
Robert Radie
CHM | Chairman | 60 | 20-03-30 |
Joan Lau
BRD | Director/Board Member | 54 | 23-10-16 |
Mark Ravich
BRD | Director/Board Member | 71 | 17-05-31 |
Andrea Smiley
BRD | Director/Board Member | 56 | 20-12-10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 29,334,617 | 28,453,128 ( 97.00 %) | 0 | 97.00 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.17% | 48.7M | |
+33.46% | 701B | |
+26.24% | 570B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 322B | |
+0.74% | 209B | |
+2.95% | 212B | |
-6.05% | 205B | |
-3.61% | 157B |
- Stock
- Equities
- Stock Rockwell Medical, Inc. - Nasdaq
- Company Rockwell Medical, Inc.